PCRX vs ABT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Mar 30, 2026

PCRX

60.2
AI Score
VS
PCRX Wins

ABT

55.8
AI Score

Investment Advisor Scores

PCRX

60score
Recommendation
BUY

ABT

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PCRX ABT Winner
Forward P/E 9.6712 18.5529 PCRX
PEG Ratio 11.2121 1.5219 ABT
Revenue Growth 5.1% 4.4% PCRX
Earnings Growth -88.4% -80.9% ABT
Tradestie Score 60.2/100 55.8/100 PCRX
Profit Margin 1.0% 14.7% ABT
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD PCRX

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.